The live price of these shares, therefore, offers a window into institutional sentiment. Because energy giants like Shell are often viewed as defensive stocks—reliable dividend payers in volatile times—a rising RDSB price often signals a "flight to safety." When growth stocks falter amid inflation fears, capital flows into energy giants. Observing the live price allows analysts to see this rotation of capital in real-time, marking the exact moments when investors abandon riskier assets for the steady cash flows of an oil major.
Shell removed its dual-listing structure (A and B shares) to become more agile.
In , the company officially scrapped this structure to increase "capital and portfolio flexibility". This involved moving its tax residence entirely to the UK and dropping "Royal Dutch" from its name to become Shell PLC . For most investors, RDSB holdings were automatically converted to the new SHEL ticker on a one-for-one basis. Key Performance Metrics for Investors
As of , here is the live performance for the unified Shell share price on the London Stock Exchange : Current Price: 3,109.50 GBX Day's Change: -9.50 (-0.30%) Day's Range: 3,078.00 – 3,115.50 GBX 52-Week High: 3,592.00 GBX Dividend Yield: ~3.54% Shell PLC (SHEL) GBX 3,119.00 -0.30% today As of 8 May, 9:54 PM GST • Disclaimer 8 May 2026 11:05 AM - 9:54 PM Open3,109.50 Mkt cap$236.84B USD 52-wk high3,592.00 High3,115.50 P/E ratio13.20 52-wk low2,403.50 Low3,078.00 Div yield3.54% Why did RDSB change to SHEL?
I've tried other similar services in the past, but RDSB Live Share Price stands out for its reliability and speed. I appreciate the attention to detail and commitment to providing accurate data.
Class B shares, primarily UK-sourced and generally exempt from Dutch withholding tax.
Historically, Shell operated with a complex "dual-listing" structure:
The interface is user-friendly and easy to navigate, making it simple to find the information I need quickly. I've found the charts and historical data to be particularly useful in helping me make informed investment decisions.